Tabula Rasa HealthCare (NASDAQ:TRHC – Get Rating) and TuanChe (NASDAQ:TC – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.
Institutional & Insider Ownership
60.9% of Tabula Rasa HealthCare shares are owned by institutional investors. Comparatively, 0.2% of TuanChe shares are owned by institutional investors. 7.3% of Tabula Rasa HealthCare shares are owned by insiders. Comparatively, 0.5% of TuanChe shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Get Tabula Rasa HealthCare alerts:Profitability
This table compares Tabula Rasa HealthCare and TuanChe's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tabula Rasa HealthCare | -49.25% | -472.90% | -12.86% |
| TuanChe | N/A | N/A | N/A |
Analyst Ratings
This is a breakdown of current ratings and target prices for Tabula Rasa HealthCare and TuanChe, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tabula Rasa HealthCare | 0 | 3 | 0 | 0 | 2.00 |
| TuanChe | 0 | 0 | 0 | 0 | N/A |
Tabula Rasa HealthCare currently has a consensus price target of $5.50, suggesting a potential downside of 0.18%. Given Tabula Rasa HealthCare's higher possible upside, equities research analysts clearly believe Tabula Rasa HealthCare is more favorable than TuanChe.
Valuation and Earnings
This table compares Tabula Rasa HealthCare and TuanChe's gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tabula Rasa HealthCare | $299.52 million | 0.50 | -$79.06 million | ($6.09) | -0.90 |
| TuanChe | $56.11 million | 0.24 | -$16.00 million | ($0.82) | -0.66 |
TuanChe has lower revenue, but higher earnings than Tabula Rasa HealthCare. Tabula Rasa HealthCare is trading at a lower price-to-earnings ratio than TuanChe, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Tabula Rasa HealthCare has a beta of 1.54, meaning that its stock price is 54% more volatile than the S&P 500. Comparatively, TuanChe has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500.
About Tabula Rasa HealthCare
(Get Rating)
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.
About TuanChe
(Get Rating)
TuanChe Ltd. operates as a holding company, which engages in the operation of an omni-channel automotive marketplace. It offers auto shows, group-purchase facilitation, and virtual dealership services. The company was founded by Wei Wen and Jian Chen Sun in 2010 and is headquartered in Beijing, China.
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.